Objective:

To determine the clinical response in patients with basal palpebral carcinoma treated with HeberFERON(.

Methods:

A descriptive study was carried out in patients with eyelid cell basal carcinoma tried with HeberFERON in the Cuban Institute of Ophthalmology "Ramón Pando Ferrer" from January 2013 to January 2015. The sample consisted of 10 patients who fulfilled the inclusion criteria. The study variables were: age, sex, skin color, clinical form, tumor diameter, histological subtype of the tumor, as well as the clinical response after treatment of the cases studied. In all the variables, absolute and relative frequencies were calculated.

Results:

Male gender and white-skinned subjects predominated. The clinical form ulcerative nodule, poorly differentiated histological tumor subtype, and objective clinical response were present in the patients studied.

Conclusions:

In most of the patients a good clinical answer was achieved to the treatment with HeberFERON, which becomes a new non surgical alternative.

        · resumen en Español     · texto en Español     · Español ( pdf )